Arca
Skip to content
Tools
Tools

JAK1: Tyrosine-protein kinase JAK1

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Non-membrane spanning protein tyrosine kinase that phosphorylates signal-transducing subunits of cytokine receptor complexes like IL2RB, IL10RA, IFNAR2, IL6ST, LIFR, OSMR and IL31RA.

  • Drugs that act on it: 14
  • With a US drug page: 5
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it. All act as: Tyrosine-protein kinase JAK1 inhibitor.
AbrocitinibApproved—InhibitorBoxed warning
BaricitinibApproved—InhibitorBoxed warning
BrepocitinibApproved—Inhibitor—
MomelotinibApproved—Inhibitor—
UpadacitinibApproved—InhibitorBoxed warning
Cerdulatinib——Inhibitor—
Filgotinib——Inhibitor—
GLPG-0555——Inhibitor—
Golidocitinib——Inhibitor—
INCB-047986——Inhibitor—
Itacitinib——Inhibitor—
Ruxolitinib——InhibitorBoxed warning
Solcitinib——Inhibitor—
Tricetamide——Inhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Autoinflammation, immune dysregulation, and eosinophilia
0.69
Atopic eczema
0.66
Hypothyroidism
0.57
Graft versus host disease
0.57
Crohn disease
0.56
Acquired polycythemia vera
0.55

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
JAK1

Drugs and mechanisms are from ChEMBL CHEMBL2835 (CC BY-SA 3.0). Gene name, function (UniProt P23458, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.